A multi-center, multi-organ, multi-omic prediction model for treatment-induced severe oral mucositis in nasopharyngeal carcinoma.

Autor: Nicol AJ; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Room Y910, 9/F, Block Y, Lee Shau Kee Building, Hung Hom, Kowloon, Hong Kong, China., Lam SK; Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hung Hom, Hong Kong, China., Ching JCF; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Room Y910, 9/F, Block Y, Lee Shau Kee Building, Hung Hom, Kowloon, Hong Kong, China., Tam VCW; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Room Y910, 9/F, Block Y, Lee Shau Kee Building, Hung Hom, Kowloon, Hong Kong, China., Teng X; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Room Y910, 9/F, Block Y, Lee Shau Kee Building, Hung Hom, Kowloon, Hong Kong, China., Zhang J; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Room Y910, 9/F, Block Y, Lee Shau Kee Building, Hung Hom, Kowloon, Hong Kong, China., Lee FKH; Department of Clinical Oncology, Queen Elizabeth Hospital, Yau Ma Tei, Hong Kong, China., Wong KCW; Department of Clinical Oncology, Prince of Wales Hospital, Sha Tin, Hong Kong, China., Cai J; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Room Y910, 9/F, Block Y, Lee Shau Kee Building, Hung Hom, Kowloon, Hong Kong, China.; The Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen, 518000, China., Lee SWY; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Room Y910, 9/F, Block Y, Lee Shau Kee Building, Hung Hom, Kowloon, Hong Kong, China. shara.lee@polyu.edu.hk.

Publikováno v: La Radiologia medica [Radiol Med] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.

Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.

Autor: Poon DMC; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Comprehensive Oncology Centre, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong SAR, China., Tan GM; Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chan K; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong SAR, China., Chan MTY; Division of Urology, Department of Surgery, Tuen Mun Hospital, Hong Kong, Hong Kong SAR, China., Chan TW; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong SAR, China., Kan RWM; eFLO Urology, Hong Kong, Hong Kong SAR, China., Lam MHC; Hong Kong Integrated Oncology Centre, Hong Kong, Hong Kong SAR, China., Leung CLH; Department of Surgery, Kwong Wah Hospital, Hong Kong, Hong Kong SAR, China., Wong KCW; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Kam KKH; Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Ng CF; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chiu PKF; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Jan 31; Vol. 14, pp. 1345322. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).

Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions.

Autor: Lam WKJ; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Centre for Novostics, Hong Kong Science Park, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., King AD; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Miller JA; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Liu Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Yu KJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Chua MLK; Department of Head and Neck and Thoracic Cancers, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore., Ma BBY; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Chen MY; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Center for Precision Medicine of Sun Yat-sen University, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Pinsky BA; Department of Pathology, Stanford University, Stanford, CA, USA., Lou PJ; Department of Otolaryngology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan., Woo JKS; Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Hsu WL; Master Program of Big Data in Biomedicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.; Data Science Center, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan., Simon J; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Doolan DL; Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Australia., Waterboer T; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hui EP; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Li H; Department of Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China., Tsang RK; Department of Otolaryngology-Head and Neck Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Wong KCW; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Goh JP; Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore., Vlantis AC; Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Ai QY; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China., Wong LM; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Abdullah V; Department of Otorhinolaryngology, Hong Kong Children's Hospital, Hong Kong SAR, China.; The Hong Kong College of Otorhinolaryngologists, Hong Kong SAR, China., Lin JC; Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan., Chen CJ; Genomics Research Center, Academia Sinica, Taipei, Taiwan., Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Le QT; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Lee AWM; Clinical Oncology Center, Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital, Guangdong, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong SAR, China., Ji M; Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, China., Cao S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Center for Precision Medicine of Sun Yat-sen University, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; Department of Cancer Prevention, Sun Yat-sen University Cancer Center, Guangzhou, China., Ma J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Center for Precision Medicine of Sun Yat-sen University, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Chan ATC; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Chan KCA; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Centre for Novostics, Hong Kong Science Park, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Hildesheim A; Agencia Costarricense de Investigaciones Biológicas (ACIB) - Fundacion del Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA), San José, Costa Rica.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Apr 11; Vol. 115 (4), pp. 355-364.

Malignancies in Immunoglobulin G4-related ophthalmic disease.

Autor: Lai KKH; Department of Ophthalmology, 66380Tung Wah Eastern Hospital, Hong Kong., Li EYM; 71113Hong Kong Eye Hospital, Hong Kong., Chan RYC; Department of Ophthalmology and Visual Sciences, 13621Prince of Wales Hospital, Hong Kong., Wong KCW; Department of Clinical Oncology, 13621Prince of Wales Hospital, Hong Kong., Yu JKS; Department of Clinical Oncology, 13621Prince of Wales Hospital, Hong Kong., Cheuk W; Department of Pathology, Queen Elizabeth Hospital, Hong Kong., Hui YH; Department of Nuclear Medicine, Queen Elizabeth Hospital, Hong Kong., Cheng ACO; Department of Ophthalmology, 13620Hong Kong Sanatorium & Hospital, Hong Kong., Chin JKY; Department of Ophthalmology and Visual Sciences, 13621Prince of Wales Hospital, Hong Kong., Ip SK; Department of Ophthalmology, 36658Tuen Mun Hospital, Hong Kong., Chan WH; Department of Ophthalmology, 36658Tuen Mun Hospital, Hong Kong., Kwok JSW; Department of Ophthalmology, Grantham Hospital, Hong Kong.; Department of Ophthalmology, 25809The University of Hong Kong, Hong Kong., Lam WC; Department of Ophthalmology, Grantham Hospital, Hong Kong.; Department of Ophthalmology, 25809The University of Hong Kong, Hong Kong., Io IYF; Department of Ophthalmology, 36611Caritas Medical Center, Hong Kong., Mak TST; Department of Ophthalmology, 36621United Christian Hospital, Hong Kong., Li KKW; Department of Ophthalmology, 36621United Christian Hospital, Hong Kong., Lam NM; 71113Hong Kong Eye Hospital, Hong Kong., Yip WWK; Department of Ophthalmology and Visual Sciences, 13621Prince of Wales Hospital, Hong Kong., Young AL; Department of Ophthalmology and Visual Sciences, 13621Prince of Wales Hospital, Hong Kong., Chan E; Department of Ophthalmology, 66380Tung Wah Eastern Hospital, Hong Kong., Ko CKL; Department of Ophthalmology, 66380Tung Wah Eastern Hospital, Hong Kong., Ko STC; Department of Ophthalmology, 66380Tung Wah Eastern Hospital, Hong Kong., Yuen HKL; 71113Hong Kong Eye Hospital, Hong Kong.; Department of Ophthalmology and Visual Sciences, 26451The Chinese University of Hong Kong, Hong Kong., Tham CCY; Department of Ophthalmology and Visual Sciences, 26451The Chinese University of Hong Kong, Hong Kong., Pang CP; Department of Ophthalmology and Visual Sciences, 26451The Chinese University of Hong Kong, Hong Kong., Chong KKL; Department of Ophthalmology and Visual Sciences, 13621Prince of Wales Hospital, Hong Kong.; Department of Ophthalmology and Visual Sciences, 26451The Chinese University of Hong Kong, Hong Kong.

Publikováno v: European journal of ophthalmology [Eur J Ophthalmol] 2023 Jan; Vol. 33 (1), pp. 171-181. Date of Electronic Publication: 2022 Jun 08.

Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma.

Autor: Chan DCT; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Centre for Novostics, Hong Kong Science Park, New Territories., Lam WKJ; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Centre for Novostics, Hong Kong Science Park, New Territories; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories., Hui EP; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories., Ma BBY; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories., Chan CML; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Centre for Novostics, Hong Kong Science Park, New Territories., Lee VCT; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Centre for Novostics, Hong Kong Science Park, New Territories., Cheng SH; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Centre for Novostics, Hong Kong Science Park, New Territories., Gai W; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Centre for Novostics, Hong Kong Science Park, New Territories., Jiang P; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Centre for Novostics, Hong Kong Science Park, New Territories; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories., Wong KCW; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories., Mo F; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories., Zee B; Centre for Clinical Research and Biostatistics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories., King AD; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China., Le QT; Department of Radiation Oncology, Stanford University, Stanford, USA., Chan ATC; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories., Chan KCA; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Centre for Novostics, Hong Kong Science Park, New Territories; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories., Lo YMD; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories; Centre for Novostics, Hong Kong Science Park, New Territories; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories. Electronic address: loym@cuhk.edu.hk.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Aug; Vol. 33 (8), pp. 794-803. Date of Electronic Publication: 2022 Apr 29.